Back to
JENNISON ASSOCIATES LLC
CDLX
Showing 0 of 17 quarters
Position history for
JENNISON ASSOCIATES LLC's holdings in CARDLYTICS INC
No. Jennison Associates exited its CDLX (Cardlytics) position in Q4 2022. Its Q3 2022 13F listed 50,474 shares worth $474,000. Jennison Associates already held CDLX in its Q4 2018 13F, the earliest on record, and held it in 16 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.